dr_allan_dunton

Alan Dunton appointed senior vice president at Purdue Pharma

November 20, 2015
Manufacturing and Production, Medical Communications, Research and Development

Purdue Pharma LP has announced the appointment of Alan Dunton, MD, to the role of senior vice president of Research …

keytruda

Lilly and Merck extend immuno-oncology collaboration

November 20, 2015
Medical Communications, Research and Development Eli Lilly, Merck

Eli Lilly and Merck have announced the extension of their existing collaboration to evaluate the safety and efficacy of the …

bayercross3

Bayer awaits FDA decision on new contraceptive

November 20, 2015
Medical Communications, Research and Development

Bayer has submitted a new drug application (NDA) to the FDA, seeking approval for LCS-16, an investigational hormonal intrauterine device …

abpi_logo_on_wall

PMCPA rules on two Bayer conduct breach allegations

November 20, 2015
Medical Communications, Sales and Marketing

The pharma industry regulator in the UK, the PMCPA, has ruled on two alleged breaches of the ABPI code of …

New partner drives Simon-Kucher’s Life Sciences growth in the UK

November 19, 2015
Medical Communications

The global strategy and marketing consultancy Simon-Kucher & Partners has appointed eleven new partners for 2016, with eight of them …

lyrica_advert

American Medical Association calls for ban on drug commercials

November 19, 2015
Medical Communications, Sales and Marketing

The American Medical Association (AMA) has called for a ban on the promotion of prescription products; action which it believes …

nhs_england_and_nice_logos

NHS England and NICE announce plans for new Cancer Drugs Fund

November 19, 2015
Medical Communications, Research and Development Cancer Drugs Fund, NHS England, NICE

A 12-week consultation on draft proposals for a revamped Cancer Drugs Fund (CDF) has been launched by NHS England and NICE, …

Physicians Interactive becomes Aptus Health, offering a global digital health engagement solution

November 19, 2015
Medical Communications

Physicians Interactive has announced that it has become Aptus Health, reflecting its mission of advancing health engagement and its role …

bayer_cross_2

NICE decision restricts Bayer’s Xofigo to select prostate cancer patients

November 19, 2015
Research and Development, Sales and Marketing Bayer, NICE, prostate cancer

NICE has issued its Final Appraisal Determination (FAD) recommending Bayer’s Xofigo (radium-223 dichloride) for use on the NHS in England …

fda_sign_web

FDA grants Merck and Pfizer priority review for PD-L1 cell treatment

November 19, 2015

The FDA has granted Merck and Pfizer’s avelumab Breakthrough Therapy Designation for the treatment of patients with metastatic merkel cell …

nice

Merck criticises NICE ‘no’ to personalised bowel cancer drugs

November 19, 2015
Research and Development

NICE has issued preliminary not recommending two specific personalised treatments used in combination with chemotherapy for previously untreated metastatic colorectal …

Merck

Merck KGaA completes $17bn Sigma-Aldrich acquisition

November 18, 2015
Manufacturing and Production, Sales and Marketing M&A Sigma Aldridge, Merck, acquisitions, mergers

Merck KGaA has announced the completion of its $17 billion acquisition of Sigma-Aldrich, having cleared the final regulatory hurdle and …

US Capitol building

Obama FDA commissioner nominee Califf defends big pharma ties

November 18, 2015
Sales and Marketing Bernie Sanders, FDA, FDA commissioner, Robert Califf

President Obama’s nominee to head the FDA was forced to defend his history of ties to the pharma industry as …

NICE rejects Amgen’s Repatha in draft guidance

November 18, 2015
Research and Development, Sales and Marketing Amgen, NICE, Repatha, evolocumab, high cholesterol

NICE has published draft guidance rejecting Amgen’s Repatha as a treatment for people with high cholesterol.   

Takeda oncology

Challenges in oncology R&D

November 18, 2015
Manufacturing and Production, Research and Development Dixie-Lee Esseltine, Takeda, Takeda oncology, Velcade, multiple myeloma, oncology

Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …

FDA sign

FDA accepts regulatory submission for Novartis biosimilar

November 18, 2015
Research and Development, Sales and Marketing Neulasta, Novartis, Sandoz, biosimilar, pegfilgrastim

Novartis’ generics unit Sandoz has announced it has had its Biologics License Application (BLA) for a proposed biosimilar to Amgen’s …

pills

Global drug spending will rise 30% by 2020, to $1.4 trillion

November 18, 2015
Research and Development IMS Health, OTC, drug spending, emerging markets, generics, prescribing

Global spending on drugs will increase 30% to $1.4 trillion by 2020, as more patients get access to treatments and …

Researcher

Scientists make possible pancreatic cancer discovery

November 18, 2015
Research and Development Pancreatic cancer

Cancer researchers say they have discovered a potential new method of treatment for pancreatic cancer that could improve survival rates.  …

The Gateway to Local Adoption Series

Latest content